Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss. (2021)
Attributed to:
Targeting the cellular metabolism to treat tissue-specific mitochondrial diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ajhg.2021.08.003
PubMed Identifier: 34626583
Publication URI: http://europepmc.org/abstract/MED/34626583
Type: Journal Article/Review
Volume: 108
Parent Publication: American journal of human genetics
Issue: 10
ISSN: 0002-9297